2010
DOI: 10.1097/01.hjh.0000378766.31971.ab
|View full text |Cite
|
Sign up to set email alerts
|

Neurogenic and Myogenic Resting Skin Blood Flowmotion in Subjects With Masked Hypertension: PP.11.441

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
16
0
1

Year Published

2012
2012
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 12 publications
(18 citation statements)
references
References 0 publications
1
16
0
1
Order By: Relevance
“…8,11 However, only a few studies have assessed HOMA-IR in masked hypertension. [21][22][23][24] A Japanese populationbased study found only nonsignificant differences between masked hypertension, defined with home BP and the other BP groups. 21 Another study performed ambulatory BP measurement on 76 untreated, non-diabetic patients and observed significantly higher HOMA-IR in masked, white-coat and sustained hypertension than in normotension.…”
Section: Insulin Resistancementioning
confidence: 96%
See 1 more Smart Citation
“…8,11 However, only a few studies have assessed HOMA-IR in masked hypertension. [21][22][23][24] A Japanese populationbased study found only nonsignificant differences between masked hypertension, defined with home BP and the other BP groups. 21 Another study performed ambulatory BP measurement on 76 untreated, non-diabetic patients and observed significantly higher HOMA-IR in masked, white-coat and sustained hypertension than in normotension.…”
Section: Insulin Resistancementioning
confidence: 96%
“…Although patients with MS frequently have high-normal or elevated office, home and ambulatory BP levels, only a few studies have touched briefly on MS or insulin resistance in masked hypertension. 5,7,[14][15][16][17][18][19][20][21][22][23][24] Most of these studies were based on selected patient groups [14][15][16][17][18][19][20][22][23][24] and only a few of them reported the criteria used to define MS. [14][15][16] The majority of them did not find any significant differences between BP subgroups.…”
Section: Introductionmentioning
confidence: 99%
“…Other studies that have performed spectral analysis on laser-Doppler flux similarly found no difference in the PSD during baseline conditions in early stage (Gryglewska et al, 2010b; Rossi et al, 2006) or long standing essential hypertension (Rossi et al, 2006). In contrast, Gryglewska et al 2010 found that individuals who have masked hypertension, or normal in-clinic blood pressure recordings but have consistently high ambulatory blood pressure readings, have altered basal blood flow suggesting they may have mechanistically-distinct vascular adaptations with their disease progression (Gryglewska et al, 2010b). …”
Section: Discussionmentioning
confidence: 87%
“…These periodic oscillations, or skin flowmotion, represent the influence of heart beat (0.6–2.0Hz), respiration (0.15–0.6Hz), myogenic (~0.05–0.15Hz) (Stefanovska et al, 1999), neurogenic (~0.02–0.05Hz) (Kastrup et al, 1989; Soderstrom et al, 2003), and endothelial (~0.0095–0.02Hz) influences on vascular smooth muscle relaxation (Gustafsson et al, 1993; Kvandal et al, 2003; Kvernmo et al, 1999; Rossi et al, 2008a). Spectral analysis has been performed on populations with known microvascular dysfunction such as peripheral arterial obstructive disease (Rossi et al, 2005), chronic kidney disease (Rossi et al, 2008b), diabetes (Schmiedel et al, 2007), chronic smokers (Avery et al, 2009; Rossi et al, 2007), hypercholesterolemics (Rossi et al, 2009) and essential hypertensive men and women (Gryglewska et al, 2010a; Gryglewska et al, 2010b; Rossi et al, 2006). While these studies observed altered skin flowmotion responses, many of them utilized different skin vasoreactivity tests and subject populations in which the mechanisms mediating skin blood flow are not thoroughly understood.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, the cutaneous circulation has emerged as an accessible and potentially representative vascular bed in which to examine the mechanisms that control microvascular function. It has been argued that pathology‐induced changes in cutaneous microvascular function may reflect those occurring in less accessible vascular beds and thus provide a useful surrogate in which to investigate deficits in microvascular function (Holowatz et al 2008), including those found in obesity‐associated insulin resistance (Clough et al 2011; De Boer et al 2012), diabetes (Clough et al 2011), hypertension, (Gryglewska et al 2010; Rossi et al 2011) and ageing (Gooding et al 2006; Avery et al 2009) and in smokers (Avery et al 2009).…”
mentioning
confidence: 99%